Table.

Survey Results From 301 Total Respondents at a Plenary Session on Genome Editing at ATVB|PVD Scientific Sessions 2017

Which of the following best describes your primary occupation?
 Basic scientist=74%
 Epidemiologist=1%
 Clinical researcher=12%
 Clinical practitioner=6%
 Other=7%
If you had the opportunity to receive a one-shot somatic genome-editing therapy that would permanently reduce your risk of coronary heart disease, would you do so (assuming the therapy is 100% safe)?
 Yes=69%
 No=19%
 Don’t know=12%
Would you support basic in vitro human germline genome editing research that would not culminate in pregnancy (eg, to study developmental biology)?
 Yes=68%
 No=22%
 Don’t know=10%
Would you support public (government) funding of basic in vitro human germline genome-editing research that would not culminate in pregnancy?
 Yes=71%
 No=20%
 Don’t know=10%
Do you think it would be acceptable for parents to use human germline genome editing to have a healthy biological child when there is no other means to do so?
 Yes=61%
 No=28%
 Don’t know=11%
Do you think it would be acceptable for parents to use human germline genome editing to reduce the risk of their child having a serious medical condition (eg, premature coronary heart disease or Alzheimer disease)?
 Yes=45%
 No=40%
 Don’t know=15%
Do you think it would be acceptable for parents to use human germline genome editing to increase the odds of their child having a desired trait (eg, athletic ability)?
 Yes=2%
 No=95%
 Don’t know=3%
Do you think it would be acceptable for an adult to receive somatic genome editing to acquire a desired trait (eg, athletic ability)?
 Yes=13%
 No=83%
 Don’t know=4%
Do you think it would be acceptable for an adult to receive somatic genome editing to reduce the risk of having a serious medical condition (eg, premature coronary heart disease or Alzheimer disease)?
 Yes=80%
 No=13%
 Don’t know=7%
Would you support clinical applications of human germline genome editing if the public was not asked about their opinion on the issue?
 Yes=19%
 No=72%
 Don’t know=9%
Would you support clinical applications of human germline genome editing if the public was asked about the issue but was not supportive?
 Yes=36%
 No=49%
 Don’t know=15%
Would you support the costs of clinical applications of human germline genome editing being covered by public (government) health care to ensure broad access?
 Yes=68%
 No=25%
 Don’t know=7%
  • ATVB|PVD indicates Arteriosclerosis, Thrombosis and Vascular Biology | Peripheral Vascular Disease.